<DOC>
	<DOCNO>NCT02280538</DOCNO>
	<brief_summary>The present study design test hypothesis Intra-Articular Hyaluronic Acid ( IAHA ) superior placebo slow structural progression long term symptomatic effect primary knee Osteoarthritis ( OA ) patient . The investigator perform multicenter double-blind , randomize , placebo-controlled , parallel group trial .</brief_summary>
	<brief_title>Trial Assess Structural Effect Long-term Symptomatic Relief Intra-articular Injections Hyaluronic Acid Primary Knee OA</brief_title>
	<detailed_description>The target population patient diagnosis knee osteoarthritis follow two Portuguese hospital ( Centro Hospitalar de Lisboa Norte - Hospital Santa Maria , Centro Hospitalar de Lisboa Ocidental - Hospital Egas Moniz ) . All patient select include intention-to-treat group . Then , use block randomization method assign receive either IAHA , placebo ( saline solution ) . At hospital study consist four injection IAHA , 6 month apart , plus 6 month period injection , result total follow-up period 24 month . Before new cycle follow-up consultation perform order ass pain function ( KOOS ) , quality life ( SF-36 ) , adverse event consumption acetaminophen NSAIDS regard week evaluation . X-rays perform begin follow-up , one year 6 month last cycle IAHA placebo injection ( 24 month ) . Ultrasound evaluation perform target knee time point X-rays two rheumatologist train musculoskeletal ultrasound examination . Additionally , investigator assess potential biochemical biomarkers knee OA structural progression response treatment . Measurements perform serum urine , If possible , synovial fluid aspiration perform together blood urine sample store Biobanco-IMM Instituto de Medicina Molecular analysis . Biologic sample collection perform baseline repeat 4th , 12th , 24th , 36th week , every 6 month .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Symptomatic knee OA define ACR clinical radiographic criterion KellgrenLawrence grade II III prior xrays ( take within 6 month screen visit ) screen Xray A minimum medial and/or lateral JSW target knee 2 mm Knee pain 40 mm great 100 mm visual analogue scale ( VAS ) time week inclusion Oral corticosteroid ( ≤10 mg/day prednisolone equivalent ) , NSAIDs , acetaminophen permit dose stable least one month prior baseline Body mass index great 40 kg/m2 Varus valgus deformity knee &gt; 15 degree ( assessed goniometry ) History trauma , surgery plan surgery study joint ( include arthroscopy surgery ) , joint inflammatory disease , septic arthritis and/or microcrystalline arthropathy Coagulation/platelet disorder Active malignancy , active systemic infection , contraindication MRI Potent analgesic include opiate , oral corticosteroid therapy within one month prior enrolment study stable dos ≤ 10 mg daily prednisolone equivalent Knee administration intraarticular steroid previous 3 month HA injection past year</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Knee Osteoarthritis</keyword>
	<keyword>Intra-Articular Hyaluronic Acid</keyword>
	<keyword>disease modifying</keyword>
</DOC>